Sadichha Sitaula
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Receptor Mechanisms and Signaling, Adipose Tissue and Metabolism, Computational Drug Discovery Methods, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Adropin: An endocrine link between the biological clock and cholesterol homeostasis(2017)91 cited
- → Suppression of atherosclerosis by synthetic REV-ERB agonist(2015)81 cited
- → Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation(2016)48 cited
- → International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023(2023)42 cited
- → Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity(2023)42 cited
- → Rev-erb regulation of cholesterologenesis(2017)37 cited
- → Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries(2021)29 cited
- → Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia(2017)20 cited
- → Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists(2020)19 cited
- → A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells(2020)18 cited